Syngene announces 3rd year of STEM scholarship for women with RICH
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
The submission is based on data from the STEP UP and STEP UP T2D clinical trials
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
Subscribe To Our Newsletter & Stay Updated